Targeting Inflammation in Cardiovascular Disease - From Canakinumab to Colchicine

Learn about the evolution of inflammation-targeting treatments in cardiovascular disease through a 48-minute cardiology rounds lecture delivered by Dr. Ruth McPherson, a distinguished Professor of Medicine and Director of the Atherogenomics Laboratory and Lipid Clinic at the University of Ottawa Heart Institute. Explore the progression from canakinumab to colchicine in treating cardiovascular inflammation, drawing on Dr. McPherson's extensive expertise as a Fellow of the Royal College of Physicians of Canada, American College of Physicians, and the Royal Society of Canada. Gain insights into cutting-edge approaches for managing cardiovascular disease through anti-inflammatory interventions and understand the latest developments in this crucial area of cardiac medicine.